UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 4, 2016 4:30 P.M.
Form:
S-1
CIK:
0001638287
Company Name:
Gemphire Therapeutics Inc.
File Number:
333-210815